Anesthesia in the Pediatric Patient

Megan A Brockel1, David M Polaner1, Vijaya M Vemulakonda2

  • 1Department of Anesthesiology, University of Colorado, Children's Hospital Colorado, Anschutz Medical Campus, 13123 East 16th Avenue, Aurora, CO 80045, USA.

Insights

Anesthetic risks for children have decreased, but neonates and infants face unique pulmonary and cardiovascular risks. Ongoing research investigates potential long-term neurodevelopmental effects of anesthesia in young patients.

Area of Science:

  • Pediatric Anesthesiology
  • Neurodevelopmental Toxicology

Background:

  • Anesthetic drug and monitoring advancements have reduced pediatric risks.
  • Neonates and infants exhibit higher risks for cardiovascular and pulmonary complications.
  • Emerging concerns link anesthesia to potential long-term neurodevelopmental effects in young children.

Purpose of the Study:

  • To summarize current understanding of anesthetic risks in pediatric patients, particularly neonates and infants.
  • To highlight concerns regarding potential neurodevelopmental toxicity of anesthetics in children.
  • To emphasize the need for collaborative decision-making between clinicians and parents.

Main Methods:

  • Review of existing literature on pediatric anesthesia safety.
  • Analysis of recent reports on neurodevelopmental outcomes in children exposed to anesthesia.
  • Discussion of clinical considerations for managing anesthesia in vulnerable pediatric populations.

Main Results:

  • Significant reductions in anesthetic risks for pediatric patients due to improved techniques.
  • Identified increased risks for cardiovascular and pulmonary complications in neonates and infants.
  • Highlighted ongoing research into potential anesthetic neurotoxicity in children.

Conclusions:

  • While overall anesthetic risks have decreased, neonates and infants require special consideration due to specific complications.
  • The potential for long-term neurodevelopmental effects from anesthesia in children is an active area of investigation.
  • Shared decision-making involving parents is crucial for optimizing care for vulnerable pediatric patients undergoing anesthesia.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
262
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
304
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
226
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
296
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
667
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
1.7K